NRX Pharmaceuticals (NRXP) Net Income (QoQ) (2018 - 2026)
NRX Pharmaceuticals (NRXP) Net Income (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | NRX Pharmaceuticals | 124.45 Mn | 117.75 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.58% |
| Dec 31, 2025 | -9.71% |
| Sep 30, 2025 | -12.96% |
| Jun 30, 2025 | 2.99% |
| Mar 31, 2025 | -58.28% |
| Dec 31, 2024 | 19.58% |
| Sep 30, 2024 | 57.13% |
| Jun 30, 2024 | -11.00% |
| Mar 31, 2024 | -43.81% |
| Dec 31, 2023 | 28.71% |
| Sep 30, 2023 | 23.49% |
| Jun 30, 2023 | -103.91% |
| Mar 31, 2023 | 67.77% |
| Dec 31, 2022 | -31.99% |
| Sep 30, 2022 | 4.38% |
| Jun 30, 2022 | 41.65% |
| Mar 31, 2022 | 45.04% |
| Dec 31, 2021 | 17.93% |
| Sep 30, 2021 | -31,401.05% |
| Jun 30, 2021 | 86.84% |